A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here
Sunday, 8 May 2011
Just to remind you, these are references for a preliminary ruling from the Court of Appeal (England and Wales) on the interpretation of Articles 3(a) and (b) of Regulation 469/2009 regarding the meaning of ‘product protected by a basic patent in force’ and whether there exist further or different criteria in respect of a medicinal product comprising more than one active ingredient or for a multi-disease vaccine.